Clonal dynamics following p53 loss of heterozygosity in Kras-driven cancers.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 27585860.
- Also identified by DOI 10.1038/ncomms12685 and PMC identifier 5025814.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Although it has become increasingly clear that cancers display extensive cellular heterogeneity, the spatial growth dynamics of genetically distinct clones within developing solid tumours remain poorly understood. Here we leverage mosaic analysis with double markers (MADM) to trace subclonal populations retaining or lacking p53 within oncogenic Kras-initiated lung and pancreatic tumours. In both models, p53 constrains progression to advanced adenocarcinomas. Comparison of lineage-related p53 knockout and wild-type clones reveals a minor role of p53 in suppressing cell expansion in lung adenomas. In contrast, p53 loss promotes both the initiation and expansion of low-grade pancreatic intraepithelial neoplasia (PanINs), likely through differential expression of the p53 regulator p19ARF. Strikingly, lineage-related cells are often dispersed in lung adenomas and PanINs, contrasting with more contiguous growth of advanced subclones. Together, these results support cancer type-specific suppressive roles of p53 in early tumour progression and offer insights into clonal growth patterns during tumour development.
Medical subject headings
- Carcinogenesis
- Carcinoma, Pancreatic Ductal
- Cyclin-Dependent Kinase Inhibitor p16
- Lung Neoplasms
- Pancreatic Neoplasms
- Proto-Oncogene Proteins p21(ras)
- Tumor Suppressor Protein p53